Cargando…

Strongyloides Hyperinfection Syndrome Triggered by a Single Dose of Dexamethasone Administered for Fetal Lung Development

Strongyloides hyperinfection syndrome is a rare manifestation caused by the Strongyloides stercoralis parasite and has mortality rates close to 90% if left untreated. Corticosteroids are commonly implicated as a trigger for hyperinfection syndrome in patients with Strongyloides autoinfection, and it...

Descripción completa

Detalles Bibliográficos
Autores principales: Meisenheimer, VII, John, Dattadeen, Jaraad, Thomley, Meredith, Aslam, Sadaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607639/
https://www.ncbi.nlm.nih.gov/pubmed/37900370
http://dx.doi.org/10.7759/cureus.46067
_version_ 1785127589271044096
author Meisenheimer, VII, John
Dattadeen, Jaraad
Thomley, Meredith
Aslam, Sadaf
author_facet Meisenheimer, VII, John
Dattadeen, Jaraad
Thomley, Meredith
Aslam, Sadaf
author_sort Meisenheimer, VII, John
collection PubMed
description Strongyloides hyperinfection syndrome is a rare manifestation caused by the Strongyloides stercoralis parasite and has mortality rates close to 90% if left untreated. Corticosteroids are commonly implicated as a trigger for hyperinfection syndrome in patients with Strongyloides autoinfection, and it has been suggested that even a single dose of corticosteroids can trigger hyperinfection syndrome. Here, we report a case of hyperinfection syndrome eight days after administering a single 8 mg dose of dexamethasone for fetal lung development before a late preterm, emergency cesarean section (C-section) delivery secondary to placental abruption. Prior to the C-section, the patient had been exhibiting signs of autoinfection syndrome, cough, and abdominal pain, for several months. Following corticosteroid administration, she had sequelae of Strongyloides hyperinfection syndrome, including gram-negative bacteremia, undulating fevers, protein wasting enteropathy, and hypersensitivity pneumonitis. Sputum cultures were positive for Strongyloides, and after treatment with ivermectin and albendazole, the patient fully recovered. Strongyloides hyperinfection syndrome is a documented consequence of short courses of corticosteroids. Still, this case is unique because the patient only received a single dose of corticosteroids before developing hyperinfection syndrome. Clinicians must recognize patients at risk for Strongyloides hyperinfection syndrome and understand the risks of administering corticosteroids to patients harboring the parasite.
format Online
Article
Text
id pubmed-10607639
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-106076392023-10-28 Strongyloides Hyperinfection Syndrome Triggered by a Single Dose of Dexamethasone Administered for Fetal Lung Development Meisenheimer, VII, John Dattadeen, Jaraad Thomley, Meredith Aslam, Sadaf Cureus Internal Medicine Strongyloides hyperinfection syndrome is a rare manifestation caused by the Strongyloides stercoralis parasite and has mortality rates close to 90% if left untreated. Corticosteroids are commonly implicated as a trigger for hyperinfection syndrome in patients with Strongyloides autoinfection, and it has been suggested that even a single dose of corticosteroids can trigger hyperinfection syndrome. Here, we report a case of hyperinfection syndrome eight days after administering a single 8 mg dose of dexamethasone for fetal lung development before a late preterm, emergency cesarean section (C-section) delivery secondary to placental abruption. Prior to the C-section, the patient had been exhibiting signs of autoinfection syndrome, cough, and abdominal pain, for several months. Following corticosteroid administration, she had sequelae of Strongyloides hyperinfection syndrome, including gram-negative bacteremia, undulating fevers, protein wasting enteropathy, and hypersensitivity pneumonitis. Sputum cultures were positive for Strongyloides, and after treatment with ivermectin and albendazole, the patient fully recovered. Strongyloides hyperinfection syndrome is a documented consequence of short courses of corticosteroids. Still, this case is unique because the patient only received a single dose of corticosteroids before developing hyperinfection syndrome. Clinicians must recognize patients at risk for Strongyloides hyperinfection syndrome and understand the risks of administering corticosteroids to patients harboring the parasite. Cureus 2023-09-27 /pmc/articles/PMC10607639/ /pubmed/37900370 http://dx.doi.org/10.7759/cureus.46067 Text en Copyright © 2023, Meisenheimer, VII et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Meisenheimer, VII, John
Dattadeen, Jaraad
Thomley, Meredith
Aslam, Sadaf
Strongyloides Hyperinfection Syndrome Triggered by a Single Dose of Dexamethasone Administered for Fetal Lung Development
title Strongyloides Hyperinfection Syndrome Triggered by a Single Dose of Dexamethasone Administered for Fetal Lung Development
title_full Strongyloides Hyperinfection Syndrome Triggered by a Single Dose of Dexamethasone Administered for Fetal Lung Development
title_fullStr Strongyloides Hyperinfection Syndrome Triggered by a Single Dose of Dexamethasone Administered for Fetal Lung Development
title_full_unstemmed Strongyloides Hyperinfection Syndrome Triggered by a Single Dose of Dexamethasone Administered for Fetal Lung Development
title_short Strongyloides Hyperinfection Syndrome Triggered by a Single Dose of Dexamethasone Administered for Fetal Lung Development
title_sort strongyloides hyperinfection syndrome triggered by a single dose of dexamethasone administered for fetal lung development
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607639/
https://www.ncbi.nlm.nih.gov/pubmed/37900370
http://dx.doi.org/10.7759/cureus.46067
work_keys_str_mv AT meisenheimerviijohn strongyloideshyperinfectionsyndrometriggeredbyasingledoseofdexamethasoneadministeredforfetallungdevelopment
AT dattadeenjaraad strongyloideshyperinfectionsyndrometriggeredbyasingledoseofdexamethasoneadministeredforfetallungdevelopment
AT thomleymeredith strongyloideshyperinfectionsyndrometriggeredbyasingledoseofdexamethasoneadministeredforfetallungdevelopment
AT aslamsadaf strongyloideshyperinfectionsyndrometriggeredbyasingledoseofdexamethasoneadministeredforfetallungdevelopment